CART Form 144: Restricted Shares Lapse; Insider Plans Sale of 8,161 Shares
Rhea-AI Filing Summary
Maplebear Inc. insider notice of proposed sale under Rule 144. The filing reports an upcoming sale of 8,161 common shares through Charles Schwab & Co. with an aggregate market value of $347,268 and approximate sale date of 09/19/2025 on NASDAQ. Those shares were acquired on 08/15/2025 upon restricted stock lapse from Maplebear Inc. and are noted as equity compensation. The filer also discloses two recent sales by Daniel Danker of 10,037 and 8,161 shares generating gross proceeds of $489,993 and $376,555, respectively. The form includes the standard insider representation regarding material nonpublic information.
Positive
- Compliance disclosure filed for a proposed insider sale under Rule 144, providing transparency on insider liquidity
- Source of shares disclosed as a restricted stock lapse and payment method listed as equity compensation
Negative
- Insider selling activity — 18,198 shares sold in the past three months with combined gross proceeds of $866,548, which may be viewed negatively by some investors
Insights
TL;DR: Routine insider sale notice showing equity-compensated shares becoming eligible and scheduled for sale; recent prior sales disclosed.
The filing documents a Rule 144 notice for 8,161 common shares acquired through restricted stock lapse on 08/15/2025 and designated as equity compensation. The planned sale through Charles Schwab lists an aggregate market value of $347,268 and an approximate sale date of 09/19/2025 on NASDAQ. The form also records two earlier sales by Daniel Danker in the past three months totaling 18,198 shares with combined gross proceeds of $866,548. This is a compliance disclosure rather than an operational update; its primary investor implication is clarity on insider liquidity and timing.
TL;DR: Disclosure appears procedurally complete, showing post-vesting sale intent and past insider sales; no additional governance events reported.
The notice specifies the source of the shares as restricted stock lapse and records equity compensation as payment type, which aligns with typical post-vesting insider dispositions. The signer affirms absence of undisclosed material adverse information, per the form's representation. There are no disclosures of 10b5-1 plan adoption or other trading plan dates on the face of the provided content. As presented, the filing serves disclosure and compliance functions without indicating governance changes or material corporate actions.